Clinical Trial Update: A Study of TAK-341 in Treatment of Multiple System Atrophy [Phase 2]

View source ↗

Summary

Phase 2 study of TAK-341 for multiple system atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• TAK-341

Snippet

Sponsor: Takeda | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED